7 Best Psychedelic Stocks to Buy According to Analysts
As the psychedelic drug industry shifts from a speculative niche to a potential part of mainstream healthcare, investors have started to keep a careful eye on it.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 1,429.8,666,666,667 | $7,715 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.42 | 2,500 | $1,050.00 | 216,932 | 2025-12-15 | Filing | |
| $0.41 | 2,500 | $1,025.00 | 214,432 | 2025-12-15 | Filing | |
| $0.37 | 1,000 | $365.00 | 211,932 | 2025-11-21 | Filing | |
| $0.37 | 1,000 | $370.00 | 210,932 | 2025-11-20 | Filing | |
| $0.41 | 4,500 | $1,822.50 | 209,932 | 2025-11-19 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 37,507 | $232 | 0.08% |